
Denosumab With Ovarian Function Suppression and Aromatase Inhibitor Therapy in ER-Positive, Early-Stage Breast Cancer
When estradiol circulates in the body at high levels, it fuels hormone receptor–positive breast cancer. When estradiol is suppressed, bone remodeling is also suppressed. Therapies used to prevent estrogen receptor (ER)–positive breast cancer recurrence …